Description: Vystar Corporation is the creator and owner of the technology to produce Vytex Natural Rubber Latex (NRL). The Company's technology reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The Company operates in two segments: Vytex Division and Kiron Division. The Vytex Division is focused on expanding the licensing and utilization of its source natural rubber latex technology. Its Kiron Division provides sleep medicine services, including clinical and diagnostic. The Company's products and services include Natural Rubber Latex, and Clinical Sleep Diagnostics and Durable Medical Equipment. Its product portfolio includes Vytex NRL in high ammonia (HA) and low ammonia (LA) formulations. Vytex NRL is produced at the latex processor level and can be integrated into the processing environments. Vytex NRL is produced at the latex processor level and can be integrated into various processing environments.
Home Page: www.vystarcorp.com
725 Southbridge Street
Worcester,
MA
01610
United States
Phone:
508 791 9114
Officers
| Name | Title |
|---|---|
| Mr. Steven Rotman | Pres, CEO, CFO & Director |
| Mr. Matthew P. Clark | VP of Technical Sales |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.0018 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 74 |